Your browser doesn't support javascript.
loading
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs, Ephraim J; McCurdy, Shannon R; Solomon, Scott R; Wang, Tao; Herr, Megan R; Modi, Dipenkumar; Grunwald, Michael R; Nishihori, Taiga; Kuxhausen, Michelle; Fingerson, Stephanie; McKallor, Caroline; Bashey, Asad; Kasamon, Yvette L; Bolon, Yung-Tsi; Saad, Ayman; McGuirk, Joseph; Paczesny, Sophie; Gadalla, Shahinaz M; Marsh, Steven G E; Shaw, Bronwen E; Spellman, Stephen R; Lee, Stephanie J; Petersdorf, Effie W.
Afiliación
  • Fuchs EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD.
  • McCurdy SR; Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Solomon SR; Northside Hospital Cancer Institute, Blood and Marrow Transplant Program, Atlanta, GA.
  • Wang T; Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI.
  • Herr MR; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Modi D; Roswell Park Cancer Institute, Buffalo, NY.
  • Grunwald MR; Karmanos Cancer Institute, Detroit, MI.
  • Nishihori T; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Kuxhausen M; Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL.
  • Fingerson S; CIBMTR, National Marrow Donor Program/Be The Match Foundation, Minneapolis, MN.
  • McKallor C; CIBMTR, National Marrow Donor Program/Be The Match Foundation, Minneapolis, MN.
  • Bashey A; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Kasamon YL; Northside Hospital Cancer Institute, Blood and Marrow Transplant Program, Atlanta, GA.
  • Bolon YT; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD.
  • Saad A; CIBMTR, National Marrow Donor Program/Be The Match Foundation, Minneapolis, MN.
  • McGuirk J; Division of Hematology, Ohio State University, Columbus, OH.
  • Paczesny S; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS.
  • Gadalla SM; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
  • Marsh SGE; Division of Cancer Epidemiology and Genetics, National Institutes of Health, National Cancer Institute, Clinical Genetics Branch, Rockville, MD.
  • Shaw BE; Anthony Nolan Research Institute-University College London Cancer Institute, Royal Free Campus, London, United Kingdom; and.
  • Spellman SR; Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI.
  • Lee SJ; CIBMTR, National Marrow Donor Program/Be The Match Foundation, Minneapolis, MN.
  • Petersdorf EW; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
Blood ; 139(10): 1452-1468, 2022 03 10.
Article en En | MEDLINE | ID: mdl-34724567
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Moldova
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Moldova